Replies to post #418441 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

During data lock, we've received a lot of info about the trial. It has been confirmed 4 times, as well as in Q10's, what the process is. It shouldn't be a secret, that this consist of six phases getting to a publication correlated with TLD. It was announced BEFORE data lock, before being unblinded.

In mid September (the last public statements prior to Oct 5) they said the hoped for results in a few weeks, by end of the month.

It was AFTER Oct 5 that they first said the TLD had to be coordinated with the publication. Even then they have never said the TLD has to wait on publication.

Here is a clue. There is a massive problem they are failing to disclose that is causing the TLD not to be PR'd.

People talk about delays like this being normal. Complete BS. If anybody has invested in biotech they have never seen this.